Cargando…
Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
[Image: see text] Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor effects are not always satisfactory due to the limited penetration and retention. As we all know, there is a paradox that nanoparticles with large sizes tend to distribute around tumor blood ve...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047275/ https://www.ncbi.nlm.nih.gov/pubmed/32123729 http://dx.doi.org/10.1021/acscentsci.9b01139 |
_version_ | 1783502107312128000 |
---|---|
author | Yu, Wenqi Liu, Rui Zhou, Yang Gao, Huile |
author_facet | Yu, Wenqi Liu, Rui Zhou, Yang Gao, Huile |
author_sort | Yu, Wenqi |
collection | PubMed |
description | [Image: see text] Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor effects are not always satisfactory due to the limited penetration and retention. As we all know, there is a paradox that nanoparticles with large sizes tend to distribute around tumor blood vessels rather than penetrate into tumor parenchyma, while smaller sizes can penetrate deeply but with poor tumor retention. In recent days, an intelligent, size-tunable strategy provided a solution to determine the size problem of nanoparticles and exhibited good application prospects. In this review, we summarize series of stimuli-induced aggregation and shrinkage strategies for tumor targeted drug delivery, which can significantly increase the retention and penetration of nanodrugs in tumor sites at the same time, thus promoting treatment efficacy. Internal (enzymes, pH, and redox) and external (light and temperature) stimuli are introduced to change the morphology of the original nanodrugs through protonation, hydrophobization, hydrogen bond, π–π stacking and enzymolysis-resulted click reactions or dissociation, etc. Apart from applications in oncotherapy, size-tunable strategies also have a great prospect in the diagnosis and real time bioimaging fields, which are also introduced in this review. Finally, the potential challenges for application and future directions are thoroughly discussed, providing guidance for further clinical transformation. |
format | Online Article Text |
id | pubmed-7047275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-70472752020-03-02 Size-Tunable Strategies for a Tumor Targeted Drug Delivery System Yu, Wenqi Liu, Rui Zhou, Yang Gao, Huile ACS Cent Sci [Image: see text] Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor effects are not always satisfactory due to the limited penetration and retention. As we all know, there is a paradox that nanoparticles with large sizes tend to distribute around tumor blood vessels rather than penetrate into tumor parenchyma, while smaller sizes can penetrate deeply but with poor tumor retention. In recent days, an intelligent, size-tunable strategy provided a solution to determine the size problem of nanoparticles and exhibited good application prospects. In this review, we summarize series of stimuli-induced aggregation and shrinkage strategies for tumor targeted drug delivery, which can significantly increase the retention and penetration of nanodrugs in tumor sites at the same time, thus promoting treatment efficacy. Internal (enzymes, pH, and redox) and external (light and temperature) stimuli are introduced to change the morphology of the original nanodrugs through protonation, hydrophobization, hydrogen bond, π–π stacking and enzymolysis-resulted click reactions or dissociation, etc. Apart from applications in oncotherapy, size-tunable strategies also have a great prospect in the diagnosis and real time bioimaging fields, which are also introduced in this review. Finally, the potential challenges for application and future directions are thoroughly discussed, providing guidance for further clinical transformation. American Chemical Society 2020-01-21 2020-02-26 /pmc/articles/PMC7047275/ /pubmed/32123729 http://dx.doi.org/10.1021/acscentsci.9b01139 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Yu, Wenqi Liu, Rui Zhou, Yang Gao, Huile Size-Tunable Strategies for a Tumor Targeted Drug Delivery System |
title | Size-Tunable Strategies for a Tumor Targeted Drug
Delivery System |
title_full | Size-Tunable Strategies for a Tumor Targeted Drug
Delivery System |
title_fullStr | Size-Tunable Strategies for a Tumor Targeted Drug
Delivery System |
title_full_unstemmed | Size-Tunable Strategies for a Tumor Targeted Drug
Delivery System |
title_short | Size-Tunable Strategies for a Tumor Targeted Drug
Delivery System |
title_sort | size-tunable strategies for a tumor targeted drug
delivery system |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047275/ https://www.ncbi.nlm.nih.gov/pubmed/32123729 http://dx.doi.org/10.1021/acscentsci.9b01139 |
work_keys_str_mv | AT yuwenqi sizetunablestrategiesforatumortargeteddrugdeliverysystem AT liurui sizetunablestrategiesforatumortargeteddrugdeliverysystem AT zhouyang sizetunablestrategiesforatumortargeteddrugdeliverysystem AT gaohuile sizetunablestrategiesforatumortargeteddrugdeliverysystem |